-transparent.png){kind=logo}
Gamma-aminobutyric acid (GABA) levels in the CSF were measured in 9 normal individuals, 17 drug-free schizophrenic patients and 10 of these same schizophrenic patients after neuroleptic treatment. There was no significant difference between CSF level of GABA in the control group compared to those in schizophrenic patients; however, 6 of the 7 lowest GABA levels were from schizophrenic patients. There was a significant decline of 12 per cent in mean GABA levels in the CSF after a mean of two months of neuroleptic treatment.
Related Publications
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
September 1980,
Lancet (London, England),
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
December 1988,
Journal of the neurological sciences,
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
January 1980,
Neuropsychobiology,
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
January 1980,
Lancet (London, England),
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
February 1979,
Lancet (London, England),
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
September 2007,
Alternative medicine review : a journal of clinical therapeutic,
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
July 1986,
Casopis lekaru ceskych,
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
January 1993,
Schizophrenia research,
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
February 1968,
Nihon seirigaku zasshi. Journal of the Physiological Society of Japan,
D Lichtshtein, and
J Dobkin, and
R P Ebstein, and
J Biederman, and
R Rimon, and
R H Belmaker
December 1976,
Psychopharmacology,
